# | Title | Journal | Year | Citations |
---|
1 | Staging of brain pathology related to sporadic Parkinson’s disease | Neurobiology of Aging | 2003 | 8,567 |
2 | Inflammation and Alzheimer's disease | Neurobiology of Aging | 2000 | 4,069 |
3 | Staging of alzheimer's disease-related neurofibrillary changes | Neurobiology of Aging | 1995 | 1,943 |
4 | Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories | Neurobiology of Aging | 1997 | 1,469 |
5 | When does age-related cognitive decline begin? | Neurobiology of Aging | 2009 | 1,334 |
6 | New stereological methods for counting neurons | Neurobiology of Aging | 1993 | 897 |
7 | Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging | Neurobiology of Aging | 2010 | 885 |
8 | Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly | Neurobiology of Aging | 2017 | 870 |
9 | Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease | Neurobiology of Aging | 1997 | 865 |
10 | Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment | Neurobiology of Aging | 2006 | 854 |
11 | Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease | Neurobiology of Aging | 2003 | 840 |
12 | Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease | Neurobiology of Aging | 2004 | 834 |
13 | Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease | Neurobiology of Aging | 1997 | 830 |
14 | Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ | Neurobiology of Aging | 2000 | 809 |
15 | Effects of age on tissues and regions of the cerebrum and cerebellum | Neurobiology of Aging | 2001 | 809 |
16 | Components of postural dyscontrol in the elderly: A review | Neurobiology of Aging | 1989 | 790 |
17 | The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease | Neurobiology of Aging | 1991 | 781 |
18 | Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis | Neurobiology of Aging | 2009 | 766 |
19 | Age-related alterations in white matter microstructure measured by diffusion tensor imaging | Neurobiology of Aging | 2005 | 751 |
20 | Neuron numbers and dendritic extent in normal aging and Alzheimer's disease | Neurobiology of Aging | 1987 | 746 |
21 | What is physiologic complexity and how does it change with aging and disease? | Neurobiology of Aging | 2002 | 729 |
22 | Oxidative stress in brain agingImplications for therapeutics of neurodegenerative diseases | Neurobiology of Aging | 2002 | 715 |
23 | The impact of age, weight and gender on BDNF levels in human platelets and plasma | Neurobiology of Aging | 2005 | 710 |
24 | Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease | Neurobiology of Aging | 1997 | 701 |
25 | Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease | Neurobiology of Aging | 1988 | 673 |
26 | Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling | Neurobiology of Aging | 2010 | 659 |
27 | Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease | Neurobiology of Aging | 1998 | 653 |
28 | Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” | Neurobiology of Aging | 1998 | 628 |
29 | Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1 | Neurobiology of Aging | 2002 | 628 |
30 | Vascular risk factors for Alzheimer’s disease: | Neurobiology of Aging | 2000 | 618 |
31 | Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volume | Neurobiology of Aging | 2004 | 617 |
32 | Sex, stress and the hippocampus: allostasis, allostatic load and the aging process | Neurobiology of Aging | 2002 | 612 |
33 | PET imaging of amyloid deposition in patients with mild cognitive impairment | Neurobiology of Aging | 2008 | 611 |
34 | Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI | Neurobiology of Aging | 2011 | 611 |
35 | Body mass index is associated with biological CSF markers of core brain pathology in Alzheimer's disease | Neurobiology of Aging | 2012 | 589 |
36 | Measures of brain morphology and infarction in the framingham heart study: establishing what is normal | Neurobiology of Aging | 2005 | 588 |
37 | Identification of normal and pathological aging in prospectively studied nondemented elderly humans | Neurobiology of Aging | 1992 | 580 |
38 | Regionally specific loss of neurons in the aging human hippocampus | Neurobiology of Aging | 1993 | 572 |
39 | Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype | Neurobiology of Aging | 2006 | 560 |
40 | Glia and their cytokines in progression of neurodegeneration | Neurobiology of Aging | 2005 | 558 |
41 | Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease | Neurobiology of Aging | 2009 | 558 |
42 | Effects of age on volumes of cortex, white matter and subcortical structures | Neurobiology of Aging | 2005 | 552 |
43 | Hippocampus and entorhinal cortex in mild cognitive impairment and early AD | Neurobiology of Aging | 2004 | 539 |
44 | Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease | Neurobiology of Aging | 2003 | 530 |
45 | Common mechanisms of amyloid oligomer pathogenesis in degenerative disease | Neurobiology of Aging | 2006 | 513 |
46 | Hippocampal formation glucose metabolism and volume losses in MCI and AD | Neurobiology of Aging | 2001 | 511 |
47 | ApoE genotype accounts for the vast majority of AD risk and AD pathology | Neurobiology of Aging | 2004 | 509 |
48 | Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology | Neurobiology of Aging | 2001 | 501 |
49 | The role of cerebral ischemia in Alzheimer’s disease | Neurobiology of Aging | 2000 | 499 |
50 | Resting state fMRI in Alzheimer's disease: beyond the default mode network | Neurobiology of Aging | 2012 | 497 |